Forum, Summer 2013
This issue focuses on responsible prescribing of controlled substances. The Board is seeking input from licensees as it considers revising the position statement: “Policy for the use of controlled substances for the treatment of pain.” Margie Satinsky presents an article discussing HIPAA’s final Omnibus Rule. A position statement update details new revisions to current Board statements.
Reader friendly
Articles
- Doing our part to encourage responsible prescribing of controlled substances | by William A. Walker, MD
- Complying with the HIPAA final Omnibus Rule; Many aspects of the law have changed since its initial | by Marjorie A. Satinsky, MBA
- Quarterly Board Actions report, February-April 2013
- Changes to the NCCSRS New law makes improvements, eases access | by William D. Bronson
- CCNC’s Project Lazarus initiative provides additional CME opportunities in the area of chronic pain
- Controlled substances CME event set for Raleigh: October 25
- Position Statement Update
- Get engaged: Board seeks licensee input as part of chronic pain position statement review
